Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd.
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is...
advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(4)
•••
TFTheygonnasay
X
View Profile
View Bullboard History
Comment by
TFTheygonnasay
on Jan 20, 2023 8:50am
RE:RE:Johnny Lambo & MF - JL bought more shares today !
Why huge red flag?? unpaid Jonny lambo likes what Rvv is doing. Good luck with your short today!!!! Your back and forth on This deal for 2 years. How about sell and be done with it!!!
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jan 20, 2023 7:09am
Pharma giant to buy smaller firms with breakthrough science
#Bucillamine Interesting Read ! https://www.wsj.com/articles/pfizer-ceo-says-governments-havent-learned-lessons-of-pandemic-11674059353
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(163)
•••
MyAli4s
X
View Profile
View Bullboard History
Comment by
MyAli4s
on Jan 20, 2023 4:38am
RE:Johnny Lambo & MF - JL bought more shares today !
Huge red flag.
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jan 19, 2023 9:01pm
U.S. FDA Rejects Accelerated Approval for Alzheimer's Drug !
Interesting Read .. Jan. 19, 2023, at 6:18 p.m. https://www.usnews.com/news/top-news/articles/2023-01-19/eli-lilly-says-u-s-fda-rejects-accelerated-approval-for-alzheimers-drug
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jan 19, 2023 5:16pm
#RVV - An Update !
#Bucillamine https://ca.finance.yahoo.com/news/revive-therapeutics-submits-updated-briefing-215000511.html
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 19, 2023 4:50pm
New Press Release - Revive Therapeutics Submits Updated Briefing Package in Support of Upcoming Type C Meeting Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
TORONTO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announces today that it has...
read article.
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on Jan 19, 2023 10:39am
RE:RE:Johnny Lambo & MF - JL bought more shares today !
spend money, no outcome!
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on Jan 19, 2023 9:15am
RE:Johnny Lambo & MF - JL bought more shares today !
HOT AIR!, NOTHING, NOTHING UNTIL U DELIVER SOMETHING
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jan 18, 2023 9:11pm
Johnny Lambo & MF - JL bought more shares today !
#Bucillamine https://twitter.com/LamboJohnny/status/1615793183862194181
(835)
•••
CrazyProphet
X
View Profile
View Bullboard History
Post by
CrazyProphet
on Jan 18, 2023 3:36pm
Industrial alliance
BIG buyers today !
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on Jan 17, 2023 2:04pm
RE:RE:Always live life to the fullest! Life is so unpredictable !
F_U, hot air
(7)
•••
90guppy
X
View Profile
View Bullboard History
Comment by
90guppy
on Jan 17, 2023 9:15am
RE:Always live life to the fullest! Life is so unpredictable !
LOL, enough of the we got this, for once deliver, JUST FOR ONCE!!!!, you are nothing until you deliver, nothing but HOT AIR!, HOT AIR!
(835)
•••
CrazyProphet
X
View Profile
View Bullboard History
Post by
CrazyProphet
on Jan 17, 2023 6:43am
Better buy your cheap tickets
while you can because explosion is imminent
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jan 13, 2023 7:14pm
Pfizer vaccine led to a higher risk of ischemic stroke !
#Bucillamine https://www.politico.com/news/2023/01/13/cdc-fda-pfizer-bivalent-vaccine-possible-strokes-00077933
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jan 13, 2023 7:07pm
New COVID subvariant is now dominant across the U.S !
#Bucillamine https://www.marketwatch.com/story/new-covid-subvariant-is-now-dominant-across-the-u-s-accounting-for-43-of-all-new-cases-in-latest-week-cdc-says-11673624990
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims